KRAS and malignant colon neoplasm: Oncogenic pathways, including KRAS/BRAF that occur in high frequency in colon cancer [8-10], circumvent the canonical HH-GLI axis by converging on and further driving GLI to a higher activating state in tumor cells, promoting cellular proliferation, tumor progression and survival [7, 11-13].